Strategies for Taste Masking of Orodispersible Dosage Forms: Time, Concentration, and Perception

Abstract

Orodispersible dosage forms, characterized as quick dissolving and swallowing without water, have recently gained great attention from the pharmaceutical industry, as these forms can satisfy the needs of children, the elderly, and patients suffering from mental illnesses. However, poor taste by thorough exposure of the drugs’ dissolution in the oral cavity hinders the effectiveness of the orodispersible dosage forms. To bridge this gap, we put forward three taste-masking strategies with respect to the intensity of time, concentration, and perception. We further investigated the raw material processing, the composition of auxiliary material, formulation techniques, and process control in each strategy and drew conclusions about their effects on taste masking.

Revolutionizing Cancer Treatment: Biopolymer‐Based Aerogels as Smart Platforms for Targeted Drug Delivery

“…Salts dissolved in saliva create a salting-out effect, preventing the dissolution of water-soluble polymers. [80,95] The charge screening effect plays a pivotal role in dictating the swelling behavior of biopolymer networks by influencing the electrostatic interactions within these materials. When biopolymers containing charged groups are immersed in a solution, these groups attract ions from the surroundings, leading to an interaction that screens the charges on the biopolymer.…”

“…Salts dissolved in saliva create a salting‐out effect, preventing the dissolution of water‐soluble polymers. [ 80,95 ]…”

Alginate Based Core–Shell Capsules Production through Coextrusion Methods: Recent Applications

“…Several drugs and nutraceuticals have an unpleasant taste, especially in liquid dosage forms. To overcome this issue, they are often formulated with flavors and sweeteners to mask the bitterness associated with the active and inactive ingredients [56]. In this way, the bitter taste reduction can enhance the acceptability and adherence to medication and complements.…”

Evaluation of two different orally disintegrating tablet formulations containing flurbiprofen inclusion complex and its solid dispersion

“…To prove the formulation's prospective applicability, stability experiments were carried out at 25 ± 2 °C, 60 ± 5 % RH, 40 ± 2 °C, 75 ± 5 % RH for the time, and the formulation was subjected to a drug assay, hardness, and appearance qualities [16][17][18]. All ODTs retained their white color and rounded shape throughout stability studies.…”